Hsieh and colleagues demonstrated that mTOR enhances the migration and invasion of prostate cancer cells by affecting certain genes that are controlled by translation, and developed an ATP site inhibitor of mTOR that prevents prostate cancer metastasis [67]. Here, MTOR is linked to prostate carcinoma.